Amsterdam, NL – The Journal of Alzheimer's Disease (JAD) is pleased to announce that the joint recipients of the 2020 Alzheimer Award are Christin Nance, BA...
Amsterdam, NL – The Journal of Parkinson's Disease (JPD) and its publisher IOS Press are proud to announce that JPD's Journal Impact Factor has increased to 5...
Amsterdam NL – The SARS-CoV-19 virus initially has a limited capability to invade, attacking only one intracellular genetic target, the aryl hydrocarbon...
Amsterdam, NL – The advent of therapeutic interventions for spinal muscular atrophy (SMA) has increased the importance of presymptomatic diagnosis and treatment...
Amsterdam, NL – Solar energy is considered by some to be the ultimate solution to address the current energy crisis and global warming and the environmental...
Amsterdam, NL – Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson’s...
Amsterdam, NL – Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons...
Amsterdam, NL – Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease (PD). In...
Amsterdam, NL – Two purines, caffeine and urate, have been associated with a reduced risk of Parkinson's disease (PD) in multiple study groups and populations...
Ancona, Italy – COVID-19 disease is characterized by serious clinical manifestations which could require urgent hospitalization. Prolonged hospitalization, with...
Cologne, Germany – Exercise in older adults, even at an advanced stage of dementia, is an important strategy to maintain independence in everyday living and to...
Amsterdam, NL – Clinical neuropsychology and psychology have evolved as diagnostic and treatment-oriented disciplines necessary for individuals with...
